These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 34657790)

  • 1. Hyaluronan heterogeneity in pancreatic ductal adenocarcinoma: Primary tumors compared to sites of metastasis.
    Placencio-Hickok VR; Lauzon M; Moshayedi N; Guan M; Kim S; Nissen N; Lo S; Pandol S; Larson BK; Gong J; Hendifar AE; Osipov A
    Pancreatology; 2022 Jan; 22(1):92-97. PubMed ID: 34657790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is hyaluronan deposition in the stroma of pancreatic ductal adenocarcinoma of prognostic significance?
    Gebauer F; Kemper M; Sauter G; Prehm P; Schumacher U
    PLoS One; 2017; 12(6):e0178703. PubMed ID: 28582436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of hyaluronan in pancreatic cancer biology and therapy: Once again in the spotlight.
    Sato N; Kohi S; Hirata K; Goggins M
    Cancer Sci; 2016 May; 107(5):569-75. PubMed ID: 26918382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A MicroRNA Signature Identifies Pancreatic Ductal Adenocarcinoma Patients at Risk for Lymph Node Metastases.
    Nishiwada S; Sho M; Banwait JK; Yamamura K; Akahori T; Nakamura K; Baba H; Goel A
    Gastroenterology; 2020 Aug; 159(2):562-574. PubMed ID: 32376411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer.
    Whatcott CJ; Diep CH; Jiang P; Watanabe A; LoBello J; Sima C; Hostetter G; Shepard HM; Von Hoff DD; Han H
    Clin Cancer Res; 2015 Aug; 21(15):3561-8. PubMed ID: 25695692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value, localization and correlation of PD-1/PD-L1, CD8 and FOXP3 with the desmoplastic stroma in pancreatic ductal adenocarcinoma.
    Diana A; Wang LM; D'Costa Z; Allen P; Azad A; Silva MA; Soonawalla Z; Liu S; McKenna WG; Muschel RJ; Fokas E
    Oncotarget; 2016 Jul; 7(27):40992-41004. PubMed ID: 27329602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stromal hyaluronan accumulation is associated with low tumor grade and nodal metastases in pancreatic ductal adenocarcinoma.
    Larson BK; Guan M; Placencio V; Tuli R; Hendifar AE
    Hum Pathol; 2019 Aug; 90():37-44. PubMed ID: 31121193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic cancer stem cells may define tumor stroma characteristics and recurrence patterns in pancreatic ductal adenocarcinoma.
    Askan G; Sahin IH; Chou JF; Yavas A; Capanu M; Iacobuzio-Donahue CA; Basturk O; O'Reilly EM
    BMC Cancer; 2021 Apr; 21(1):385. PubMed ID: 33836674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The predictive value and role of stromal tumor-infiltrating lymphocytes in pancreatic ductal adenocarcinoma (PDAC).
    Lianyuan T; Dianrong X; Chunhui Y; Zhaolai M; Bin J
    Cancer Biol Ther; 2018 Apr; 19(4):296-305. PubMed ID: 29313457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma.
    Stratford JK; Bentrem DJ; Anderson JM; Fan C; Volmar KA; Marron JS; Routh ED; Caskey LS; Samuel JC; Der CJ; Thorne LB; Calvo BF; Kim HJ; Talamonti MS; Iacobuzio-Donahue CA; Hollingsworth MA; Perou CM; Yeh JJ
    PLoS Med; 2010 Jul; 7(7):e1000307. PubMed ID: 20644708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronan stimulates pancreatic cancer cell motility.
    Cheng XB; Kohi S; Koga A; Hirata K; Sato N
    Oncotarget; 2016 Jan; 7(4):4829-40. PubMed ID: 26684359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of CDX2 expression in diagnosing pancreatic ductal adenocarcinoma and predicting prognosis.
    Xiao W; Hong H; Awadallah A; Zhou L; Xin W
    PLoS One; 2014; 9(1):e86853. PubMed ID: 24489794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma.
    Hingorani SR; Zheng L; Bullock AJ; Seery TE; Harris WP; Sigal DS; Braiteh F; Ritch PS; Zalupski MM; Bahary N; Oberstein PE; Wang-Gillam A; Wu W; Chondros D; Jiang P; Khelifa S; Pu J; Aldrich C; Hendifar AE
    J Clin Oncol; 2018 Feb; 36(4):359-366. PubMed ID: 29232172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual Stromal Targeting Sensitizes Pancreatic Adenocarcinoma for Anti-Programmed Cell Death Protein 1 Therapy.
    Blair AB; Wang J; Davelaar J; Baker A; Li K; Niu N; Wang J; Shao Y; Funes V; Li P; Pachter JA; Maneval DC; Dezem F; Plummer J; Chan KS; Gong J; Hendifar AE; Pandol SJ; Burkhart R; Zhang Y; Zheng L; Osipov A
    Gastroenterology; 2022 Nov; 163(5):1267-1280.e7. PubMed ID: 35718227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Concept of Stroma AReactive Invasion Front Areas (SARIFA) as a new prognostic biomarker for lipid-driven cancers holds true in pancreatic ductal adenocarcinoma.
    Grochowski P; Grosser B; Sommer F; Probst A; Waidhauser J; Schenkirsch G; Reitsam NG; Märkl B
    BMC Cancer; 2024 Jun; 24(1):768. PubMed ID: 38926671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune Cell and Stromal Signature Associated With Progression-Free Survival of Patients With Resected Pancreatic Ductal Adenocarcinoma.
    Mahajan UM; Langhoff E; Goni E; Costello E; Greenhalf W; Halloran C; Ormanns S; Kruger S; Boeck S; Ribback S; Beyer G; Dombroswki F; Weiss FU; Neoptolemos JP; Werner J; D'Haese JG; Bazhin A; Peterhansl J; Pichlmeier S; Büchler MW; Kleeff J; Ganeh P; Sendler M; Palmer DH; Kohlmann T; Rad R; Regel I; Lerch MM; Mayerle J
    Gastroenterology; 2018 Nov; 155(5):1625-1639.e2. PubMed ID: 30092175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma.
    Yan TT; Fu XL; Li J; Bian YN; Liu DJ; Hua R; Ren LL; Li CT; Sun YW; Chen HY; Fang JY; Hong J
    Oncotarget; 2015 Nov; 6(35):37028-42. PubMed ID: 26498693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinically Relevant Biology of Hyaluronic Acid in the Desmoplastic Stroma of Pancreatic Ductal Adenocarcinoma.
    Jahedi H; Ramachandran A; Windsor J; Knowlton N; Blenkiron C; Print CG
    Pancreas; 2022 Oct; 51(9):1092-1104. PubMed ID: 37078930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal hyaluronan accumulation is associated with low immune response and poor prognosis in pancreatic cancer.
    Tahkola K; Ahtiainen M; Mecklin JP; Kellokumpu I; Laukkarinen J; Tammi M; Tammi R; Väyrynen JP; Böhm J
    Sci Rep; 2021 Jun; 11(1):12216. PubMed ID: 34108626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCR4--A Prognostic and Clinicopathological Biomarker for Pancreatic Ductal Adenocarcinoma: A Meta-Analysis.
    Krieg A; Riemer JC; Telan LA; Gabbert HE; Knoefel WT
    PLoS One; 2015; 10(6):e0130192. PubMed ID: 26091099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.